What is CVE-2023-22868?

CVE-2023-22868 is a medium-severity vulnerability in IBM Aspera Faspex, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2023-02-17.

How severe is CVE-2023-22868?

Medium severity. CVSS v3 base score is 5.4 out of 10.

XSS in IBM Aspera Faspex

CVE-2023-22868

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.004 (33.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.4 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N.

Affected products

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

psirt@us.ibm.com (vendor-advisory, Patch, Vendor Advisory)
psirt@us.ibm.com (VDB Entry, vdb-entry, Vendor Advisory)

Frequently asked questions

What is CVE-2023-22868?: CVE-2023-22868 is a medium-severity vulnerability in IBM Aspera Faspex, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2023-02-17.
How severe is CVE-2023-22868?: Medium severity. CVSS v3 base score is 5.4 out of 10.